[Evaluation of the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in primary care: the PREseAP Study].
OBJECTIVE
To assess the efficacy of a comprehensive secondary prevention programme to reduce morbidity and mortality in patients who have suffered a cardiovascular (CV) event; to control CV risk factors and prophylactic treatment in order to prevent recurrence; and to improve the quality of life of patients with cardiovascular disease.


METHODS
Randomised, pragmatic, open clinical trial in primary care.


METHODS
A total of 42 primary care centres of 8 different areas in Spain.


METHODS
Men and women below 86 years old, diagnosed with coronary disease and/or stroke and/or peripheral vascular disease in the preceding year, and who have no serious or terminal disease.


METHODS
Primary care centres will be randomised to following usual care (control group), or to following a comprehensive programme of secondary prevention (intervention group).


METHODS
Cardiovascular fatal events, cardiovascular non-fatal events, total mortality and health-related quality of life (SF-36).
Brotons
C
C
Unidad de Investigación, EAP Sardenya, Equip d'Atenció Primària Sardenya, Barcelona, Spain. cbrotons@eapsardenya.net
Ariño
D
D
Borrás
I
I
Buitrago
F
F
González
M L
ML
Kloppe
P
P
Orozco
D
D
Pepió
J M
JM
Rodríguez
P
P
Rodríguez
A I
AI
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011320:Primary Health Care; D015397:Program Evaluation; D016032:Randomized Controlled Trials as Topic